Filtered By:
Procedure: Kidney Transplant
Vaccination: Vaccines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 532 results found since Jan 2013.
Sustained Clinical Response of Acquired Epidermodysplasia Verruciformis to Human Papillomavirus Vaccination in a Kidney Transplant Recipient
Actas Dermosifiliogr. 2023 Sep 11:S0001-7310(23)00729-9. doi: 10.1016/j.ad.2023.08.009. Online ahead of print.NO ABSTRACTPMID:37704170 | DOI:10.1016/j.ad.2023.08.009
Source: Actas Dermo-Sifiliograficas - September 13, 2023 Category: Dermatology Authors: M Martinez-Molina M Munera-Campos A Quer J M Carrascosa Source Type: research
Understanding Concerns about COVID-19 and Vaccination: Perspectives from Kidney Transplant Recipients
Vaccines (Basel). 2023 Jun 22;11(7):1134. doi: 10.3390/vaccines11071134.ABSTRACTThe COVID-19 pandemic poses a significant risk for immunosuppressed groups such as transplant patients. The purpose of this study was to improve our understanding of the impact of the COVID-19 pandemic on kidney transplant recipients, including their views on COVID-19 vaccination. Semi-structured interviews were conducted from December 2021 to August 2022 with 38 kidney transplant recipients who had an appointment with their transplant care team within the previous 6 months. We used qualitative thematic analysis to characterize the perspectives...
Source: Cancer Control - July 29, 2023 Category: Cancer & Oncology Authors: Sarah R MacEwan Alice A Gaughan Graham N Dixon Ramona G Olvera Willi L Tarver Saurabh Rahurkar Laura J Rush Austin D Schenk Jack Stevens Ann Scheck McAlearney Source Type: research
Kinetics of humoral immune response and severity of infection after three doses of SARS-CoV-2 mRNA vaccine in a large cohort of kidney transplant recipients
CONCLUSIONS: The kinetics of humoral response after three doses of vaccine in kidney transplant patients is characterized by a late but effective immune response against SARS-CoV-2, reducing morbidity and mortality.PMID:37458909 | DOI:10.1007/s40620-023-01650-8
Source: Journal of Nephrology - July 17, 2023 Category: Urology & Nephrology Authors: Simona Simone Francesco Pesce Giulia Font ò Virginia Pronzo Paola Pontrelli Francesca Conserva Annalisa Schirinzi Annalisa Casanova Pasquale Gallo Michele Rossini Giuseppe Lucarelli Marco Spilotros Maria Rendina Giovanni Stallone Francesca Di Serio Alfre Source Type: research
Fight Aging! Newsletter, July 17th 2023
In conclusion, the longevity-associated genotype of FLT1 may confer increased lifespan by protecting against mortality risk posed by hypertension. We suggest that FLT1 expression in individuals with longevity genotype boosts vascular endothelial resilience mechanisms to counteract hypertension-related stress in vital organs and tissues.
Resistance Exercise Slows the Onset of Pathology in a Mouse Model of Alzheimer's Disease
https://www.fightaging.org/archives/2023/07/resistance-exercise-slows-the-onset-of-pathology-in-a-mouse-model-of-alzheimers-disease/
With the caveat that mouse models of Alzheimer's...
Source: Fight Aging! - July 16, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Immunosuppression regimen modification during COVID-19 infection in kidney transplant recipients
CONCLUSIONS: We found that immunosuppressive regimen minimization did not impact the kidney function in the long-term and it might be a helpful strategy to minimize the effect of COVID-19 infection on patients' condition during the hospital stay. With all the treatments, vaccinations, and precautions, still some patients did not achieve the complete recovery compared to their pre-COVID-19 health status. Fatigue was the main reported symptom amongst all the reported symptoms.PMID:37433396 | DOI:10.1016/j.trim.2023.101883
Source: Transplant Immunology - July 11, 2023 Category: Transplant Surgery Authors: Mahmoudreza Moein Samuel J Martin Carter Whittemore Reeba Thankachan Reut Hod Dvorai Reza F Saidi Source Type: research
Efficacy of Txagevimab/Cilgavimab Prophylaxis and Vaccination on Omicron Variants (BA.1, BA.2, BA.5, BQ.1.1) in Kidney Transplant Recipients
Clin J Am Soc Nephrol. 2023 Jun 29. doi: 10.2215/CJN.0000000000000241. Online ahead of print.NO ABSTRACTPMID:37382950 | DOI:10.2215/CJN.0000000000000241
Source: Clinical Journal of the American Society of Nephrology : CJASN - June 29, 2023 Category: Urology & Nephrology Authors: Dominique Bertrand Charlotte Laurent Veronique Lem ée Ludivine Lebourg M élanie Hanoy Frank Le Roy Dorian Nezam Diana Pruteanu Steven Grange Tristan de Nattes Mathilde Lemoine Sophie Candon Dominique Guerrot Source Type: research
SARS-CoV-2 infection: a possible trigger for the recurrence of IgA nephropathy after kidney transplantation?
J Nephrol. 2023 Jun 21. doi: 10.1007/s40620-023-01684-y. Online ahead of print.ABSTRACTImmunoglobulin A nephropathy, the most common primary glomerulonephritis worldwide, is a leading cause of chronic kidney disease and end-stage kidney failure. Several cases of immunoglobulin A nephropathy relapse in native kidneys have been described after COVID-19 vaccination or SARS-CoV-2 infection. Here, we report the case of a 52-year-old kidney transplant recipient who had a stable transplant function for more than 14 years, with a glomerular filtration rate above 30 ml/min/1.73 m2. The patient had been vaccinated against COVID-19 f...
Source: Journal of Nephrology - June 21, 2023 Category: Urology & Nephrology Authors: Eric Jankowski Mandy Schlosser Thorsten Wiech Gunter Wolf Martin Busch Source Type: research
